Teclistamab for patients with heavily pretreated relapsed or refractory multiple...
Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA
Teclistamab for patients with heavily pretreated relapsed or refractory multiple myeloma ( Dr Saad Usmani - Levine Cancer Institute, Charlotte, USA )
1 Jun 2020
Denosumab in multiple myeloma patients with renal insufficiency
Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA
Denosumab in multiple myeloma patients with renal insufficiency ( Dr Elizabeth O'Donnell - Massachusetts General Hospital, Boston, USA )
30 May 2020
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell th...
Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA
CARTITUDE-1: JNJ-4528, a B-cell maturation antigen (BCMA)-directed CAR-T-cell therapy for r/r multiple myeloma ( Dr Jesus Berdeja - Sarah Cannon Research Institute, Nashville, USA )
29 May 2020
Managing Hodgkin lymphoma during the COVID-19 outbreak
Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain
Managing Hodgkin lymphoma during the COVID-19 outbreak ( Dr Anna Sureda - Hospitalet de Llobregat, Barcelona, Spain )
20 Apr 2020
Managing multiple myeloma during the COVID-19 outbreak
Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA
Managing multiple myeloma during the COVID-19 outbreak ( Dr Robert Rifkin - Rocky Mountain Cancer Centers, Denver, USA )
17 Apr 2020
Managing Hodgkin lymphoma in a COVID-19 world
Prof Andreas Engert - University Hospital of Cologne, Cologne, Germany
Managing Hodgkin lymphoma in a COVID-19 world ( Prof Andreas Engert - University Hospital of Cologne, Cologne, Germany )
17 Apr 2020
Immune checkpoint based approaches in AML and MDS
Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA
Immune checkpoint based approaches in AML and MDS ( Dr Naval Daver - University of Texas MD Anderson Cancer Center, Houston, USA )
8 Apr 2020
CARTs for the treatment of T-cell malignancies
Dr John DiPersio - Siteman Cancer Center, St. Louis, USA
CARTs for the treatment of T-cell malignancies ( Dr John DiPersio - Siteman Cancer Center, St. Louis, USA )
1 Apr 2020
Treating haematological cancers in Romania
Dr Ciprian Tomuleasa - Ion Chiricuta Clinical Research Center, Cluj Napoca, Rom...
Treating haematological cancers in Romania ( Dr Ciprian Tomuleasa -  Ion Chiricuta Clinical Research Center, Cluj Napoca, Romania )
10 Mar 2020
The landscape of haematological cancers in India
Dr Hemant Malhotra - Mahatma Gandhi Medical College Hospital, Jaipur, India
The landscape of haematological cancers in India ( Dr Hemant Malhotra - Mahatma Gandhi Medical College Hospital, Jaipur, India )
10 Mar 2020
Haematological malignancies: Latest advances from ASH 2019
Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay
Haematological malignancies: Latest advances from ASH 2019 ( Dr Eloísa Riva - Hospital de Clínicas, Montevideo, Uruguay )
10 Mar 2020
Cancer care in Argentina
Dr Maria Agustina Perusini - Hospital Italiano de Buenos Aires, Buenos Aires, Ar...
Cancer care in Argentina ( Dr Maria Agustina Perusini - Hospital Italiano de Buenos Aires, Buenos Aires, Argentina )
10 Mar 2020